Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, Aref AR, Hamblin MR, Nabavi N, Crea F, Wang Y, Ahn KS. Ashrafizaveh S, et al. Among authors: aref ar. Cancer Lett. 2021 Jun 28;508:104-114. doi: 10.1016/j.canlet.2021.03.018. Epub 2021 Mar 22. Cancer Lett. 2021. PMID: 33766750 Review.
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.
Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Hushmandi K, Rahmanian V, Entezari M, Girish YR, Sharath Kumar KS, Aref AR, Makvandi P, Ashrafizadeh M, Zarrabi A, Khan H. Mirzaei S, et al. Among authors: aref ar. Life Sci. 2021 Jul 15;277:119430. doi: 10.1016/j.lfs.2021.119430. Epub 2021 Mar 28. Life Sci. 2021. PMID: 33789144 Review.
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. Ashrafizadeh M, et al. Among authors: aref ar. Biomed Pharmacother. 2021 Sep;141:111824. doi: 10.1016/j.biopha.2021.111824. Epub 2021 Jun 25. Biomed Pharmacother. 2021. PMID: 34175815 Free article. Review.
Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer.
Ebrahimi N, Faghihkhorasani F, Fakhr SS, Moghaddam PR, Yazdani E, Kheradmand Z, Rezaei-Tazangi F, Adelian S, Mobarak H, Hamblin MR, Aref AR. Ebrahimi N, et al. Among authors: aref ar. Cell Mol Life Sci. 2022 Oct 29;79(11):572. doi: 10.1007/s00018-022-04552-3. Cell Mol Life Sci. 2022. PMID: 36308630 Review.
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions.
Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, Sharifi L, Bokaie S, Mirzaei S, Entezari M, Aref AR, Salimimoghadam S, Rashidi M, Taheriazam A, Hushmandi K. Sadrkhanloo M, et al. Among authors: aref ar. Biomed Pharmacother. 2023 Feb;158:114168. doi: 10.1016/j.biopha.2022.114168. Epub 2023 Jan 3. Biomed Pharmacother. 2023. PMID: 36916439 Free article. Review.
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N, Manavi MS, Faghihkhorasani F, Fakhr SS, Baei FJ, Khorasani FF, Zare MM, Far NP, Rezaei-Tazangi F, Ren J, Reiter RJ, Nabavi N, Aref AR, Chen C, Ertas YN, Lu Q. Ebrahimi N, et al. Among authors: aref ar. Cancer Metastasis Rev. 2024 Mar;43(1):457-479. doi: 10.1007/s10555-023-10162-7. Epub 2024 Jan 16. Cancer Metastasis Rev. 2024. PMID: 38227149 Review.
111 results